Palbociclib in patients with non–small-cell lung cancer with cdkn2a alterations: results from the targeted agent and profiling utilization registry study

Eugene R. Ahn, Pam K. Mangat, Elizabeth Garrett-Mayer, Susan Halabi, Elie G. Dib, Daniel E. Haggstrom, Kathryn B. Alguire, Carmen J. Calfa, Timothy L. Cannon, Pamela A. Crilley, Anu G. Gaba, Alissa S. Marr, Ashish Sangal, Ramya Thota, Kaitlyn R. Antonelli, Samiha Islam, Andrew L. Rygiel, Suanna S. Bruinooge, Richard L. Schilsky

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Fingerprint

Dive into the research topics of 'Palbociclib in patients with non–small-cell lung cancer with cdkn2a alterations: results from the targeted agent and profiling utilization registry study'. Together they form a unique fingerprint.

Medicine & Life Sciences